Neupath Health Stock Analysis
| NPTH Stock | CAD 0.49 0.01 2.00% |
200 Day MA 0.2591 | 50 Day MA 0.3437 | Beta 1.153 |
NeuPath Health holds a debt-to-equity ratio of 0.666. Net Debt is likely to climb to about 4.2 M in 2026, whereas Long Term Debt is likely to drop slightly above 3.9 M in 2026. NeuPath Health's financial risk is the risk to NeuPath Health stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
NeuPath Health's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. NeuPath Health's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps NeuPath Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect NeuPath Health's stakeholders.
For many companies, including NeuPath Health, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for NeuPath Health, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, NeuPath Health's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book 1.3169 | Enterprise Value Ebitda 10.7005 | Price Sales 0.335 | Shares Float 54.9 M | Wall Street Target Price 0.5 |
Given that NeuPath Health's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which NeuPath Health is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of NeuPath Health to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, NeuPath Health is said to be less leveraged. If creditors hold a majority of NeuPath Health's assets, the Company is said to be highly leveraged.
At this time, NeuPath Health's Other Stockholder Equity is fairly stable compared to the past year. Stock Based Compensation is likely to climb to about 159.3 K in 2026, whereas Common Stock is likely to drop slightly above 24.6 M in 2026. . NeuPath Health is overvalued with Real Value of 0.39 and Hype Value of 0.46. The main objective of NeuPath Health stock analysis is to determine its intrinsic value, which is an estimate of what NeuPath Health is worth, separate from its market price. There are two main types of NeuPath Health's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect NeuPath Health's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of NeuPath Health's stock to identify patterns and trends that may indicate its future price movements.
The NeuPath Health stock is traded in Canada on TSX Venture Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Canada. NeuPath Health is usually not traded on Civic Holiday, Labour Day, Thanksgiving Day, Christmas Day, Boxing Day, New Year 's Day, Family Day, Good Friday, Victoria Day, Canada Day. NeuPath Stock trading window is adjusted to America/Toronto timezone.
NeuPath |
NeuPath Stock Analysis Notes
About 18.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.32. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. NeuPath Health recorded a loss per share of 0.01. The entity last dividend was issued on the 6th of July 2020. NeuPath Health Inc. provides chronic pain management services in Canada. The company operates 13 clinics under the Centres for Pain Management and InMedic Creative Medicine brands in Ontario and Alberta. NEUPATH HEALTH operates under Medical Care Facilities classification in Exotistan and is traded on Commodity Exchange. To find out more about NeuPath Health contact the company at 905 858 1368 or learn more at https://www.neupath.com.NeuPath Health Quarterly Total Revenue |
|
NeuPath Health Investment Alerts
| NeuPath Health has some characteristics of a very speculative penny stock | |
| NeuPath Health appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 72.81 M. Net Loss for the year was (728 K) with profit before overhead, payroll, taxes, and interest of 15.16 M. | |
| Latest headline from news.google.com: NeuPath Health announces CEO transition and preliminary 2025 results - Investing.com |
NeuPath Largest EPS Surprises
Earnings surprises can significantly impact NeuPath Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-03-16 | 2021-12-31 | 0.01 | -0.0155 | -0.0255 | 255 |
NeuPath Health Thematic Classifications
In addition to having NeuPath Health stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | Health ManagementHealthcare providers, hospitals |
NeuPath Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 23.49 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate NeuPath Health's market, we take the total number of its shares issued and multiply it by NeuPath Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.NeuPath Profitablity
NeuPath Health's profitability indicators refer to fundamental financial ratios that showcase NeuPath Health's ability to generate income relative to its revenue or operating costs. If, let's say, NeuPath Health is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, NeuPath Health's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of NeuPath Health's profitability requires more research than a typical breakdown of NeuPath Health's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.01) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.05 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.05. Management Efficiency
NeuPath Health has return on total asset (ROA) of 0.0288 % which means that it generated a profit of $0.0288 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0224) %, meaning that it generated substantial loss on money invested by shareholders. NeuPath Health's management efficiency ratios could be used to measure how well NeuPath Health manages its routine affairs as well as how well it operates its assets and liabilities. At this time, NeuPath Health's Net Tangible Assets are fairly stable compared to the past year. Intangible Assets is likely to climb to about 1.1 M in 2026, whereas Other Current Assets are likely to drop slightly above 591.2 K in 2026.Examining the leadership quality of NeuPath Health offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Technical Drivers
As of the 7th of February, NeuPath Health secures the Mean Deviation of 2.88, downside deviation of 4.52, and Risk Adjusted Performance of 0.128. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of NeuPath Health, as well as the relationship between them. Please verify NeuPath Health treynor ratio, value at risk, downside variance, as well as the relationship between the maximum drawdown and potential upside to decide if NeuPath Health is priced some-what accurately, providing market reflects its recent price of 0.49 per share.NeuPath Health Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two.
NeuPath Health Outstanding Bonds
NeuPath Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. NeuPath Health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most NeuPath bonds can be classified according to their maturity, which is the date when NeuPath Health has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
NeuPath Health Predictive Daily Indicators
NeuPath Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of NeuPath Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 5912.4 | |||
| Daily Balance Of Power | (0.33) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 0.49 | |||
| Day Typical Price | 0.49 | |||
| Period Momentum Indicator | (0.01) |
NeuPath Health Forecast Models
NeuPath Health's time-series forecasting models are one of many NeuPath Health's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary NeuPath Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.NeuPath Health Debt to Cash Allocation
Many companies such as NeuPath Health, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
NeuPath Health has accumulated 5.76 M in total debt with debt to equity ratio (D/E) of 0.67, which is about average as compared to similar companies. NeuPath Health has a current ratio of 1.24, suggesting that it may not be capable to disburse its financial obligations in time and when they become due. Debt can assist NeuPath Health until it has trouble settling it off, either with new capital or with free cash flow. So, NeuPath Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like NeuPath Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for NeuPath to invest in growth at high rates of return. When we think about NeuPath Health's use of debt, we should always consider it together with cash and equity.NeuPath Health Other Current Liab Over Time
NeuPath Health Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the NeuPath Health's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of NeuPath Health, which in turn will lower the firm's financial flexibility.NeuPath Health Corporate Bonds Issued
NeuPath Net Debt
Net Debt |
|
About NeuPath Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how NeuPath Health prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling NeuPath shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as NeuPath Health. By using and applying NeuPath Stock analysis, traders can create a robust methodology for identifying NeuPath entry and exit points for their positions.
NeuPath Health Inc. provides chronic pain management services in Canada. The company operates 13 clinics under the Centres for Pain Management and InMedic Creative Medicine brands in Ontario and Alberta. NEUPATH HEALTH operates under Medical Care Facilities classification in Exotistan and is traded on Commodity Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding NeuPath Health to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Alpha Finder Now
Alpha FinderUse alpha and beta coefficients to find investment opportunities after accounting for the risk |
| All Next | Launch Module |
Additional Tools for NeuPath Stock Analysis
When running NeuPath Health's price analysis, check to measure NeuPath Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuPath Health is operating at the current time. Most of NeuPath Health's value examination focuses on studying past and present price action to predict the probability of NeuPath Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuPath Health's price. Additionally, you may evaluate how the addition of NeuPath Health to your portfolios can decrease your overall portfolio volatility.